Back to search

Pitfalls in immunohistochemical validation of tumor marker expression — Exemplified in invasive cancer of the uterine cervix

Data up to Jan 2025

Published2008
Citations17
References40

Total Citations Per Year

Abstract

References (40)

Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis

2004 • 2,891 citations

The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells

2007 • 985 citations

FIGO staging classifications and clinical practice gudelines in the management of gynecologic cancers

2000 • 871 citations

Cytokeratins 20 and 7 as biomarkers

2002 • 282 citations

Differential Expression of E-Cadherin in Lobular and Ductal Neoplasms of the Breast and Its Biologic and Diagnostic Implications

2001 • 277 citations

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

2005 • 275 citations

Overexpression of the αvβ6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival

2007 • 170 citations

Increased Cyclooxygenase-2 Expression Is Associated With Chemotherapy Resistance and Poor Survival in Cervical Cancer Patients

2002 • 159 citations

Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy

2003 • 127 citations

CD25<sup>+</sup>CD4<sup>+</sup> Regulatory T-Cells in Cancer

2005 • 112 citations

Aberrant Cell Cycle Regulation in Cervical Carcinoma

2005 • 99 citations

The p53 story: layers of complexity

2005 • 92 citations

Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis

2003 • 83 citations

c-Myc, Genome Instability, and Tumorigenesis: The Devil Is in the Details

2006 • 81 citations

LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking

2007 • 78 citations

Mechanisms Leading to COX-2 Expression and COX-2 Induced Tumorigenesis: Topical Therapeutic Strategies Targeting COX-2 Expression and Activity

2006 • 72 citations

Increased Cyclooxygenase-2 Expression Is Associated With Chemotherapy Resistance and Poor Survival in Cervical Cancer Patients

2002 • 72 citations

Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma

2001 • 71 citations

Prognostic relevance of TGF‐β1 and PAI‐1 in cervical cancer

2004 • 63 citations

Correlation between the tumoral expression of β3-integrin and outcome in cervical cancer patients who had undergone radiotherapy

2004 • 61 citations

Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study

2005 • 54 citations

Evaluation of p53 and Bcl-2 Expression as Prognostic Markers in Invasive Cervical Carcinoma Stage IIb/III Patients Treated by Radiotherapy

2002 • 41 citations

Utility of Proliferation-Associated Marker MIB-1 in Evaluating Lesions of the Uterine Cervix

1999 • 40 citations

Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease

2005 • 35 citations

Cyclins and proliferation markers in early squamous cervical carcinoma

2004 • 33 citations

CD44 family and gynaecological cancer.

2004 • 31 citations

Pd-ECGF positivity correlates with better survival, while iNOS has no predictive value for cervical carcinomas treated with radiotherapy

2003 • 26 citations

Cyclooxygenase-2 and Epidermal Growth Factor Receptor Expressions in Different Histological Subtypes of Cervical Carcinomas

2007 • 25 citations

Predicting the outcome of squamous cell carcinoma of the uterine cervix using combinations of individual tumor marker expressions.

2007 • 20 citations

Loss of MSH2 protein expression is a risk factor in early stage cervical cancer

2007 • 19 citations

P53 expression as a predictor of recurrence in cervical squamous cell carcinoma

2002 • 18 citations

c-Myc protein expression is not an independent prognostic predictor in cervical squamous cell carcinoma

2002 • 17 citations

C-myc oncoprotein expression and prognosis in patients with carcinoma of the cervix: an immunohistochemical study.

2002 • 17 citations

P16-Immunostaining Pattern as a Predictive Marker of Lymph Node Metastasis and Recurrence in Early Uterine Cervical Cancer

2006 • 13 citations

CD44v6 as a prognostic factor in cervical carcinoma FIGO stage IB.

2005 • 11 citations

Hormones and progeny of breast tumor cells

2006 • 11 citations

Correlation p53 expression and human papilloma virus deoxyribonucleic acid with clinical outcome in early uterine cervical carcinoma

2005 • 9 citations

Cervical squamous cell carcinoma

2009 • 8 citations

Expression of thymidine phosphorylase as an effect prediction factor for uterine cervical squamous cell carcinoma after radiotherapy: an immunohistochemical study

2006 • 5 citations

Markers of apoptosis in stage IB squamous cervical carcinoma

2005 • 5 citations

Cited By (0)

Loading...
Pitfalls in immunohistochemical validation of tumor marker expression — Exemplified in… (2008) – Gynecologic Oncology | Metascience Observatory Explorer